Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Debt to Equity: 2009-2024

Historic Debt to Equity for Ironwood Pharmaceuticals (IRWD) over the last 10 years, with Dec 2024 value amounting to -$1.28.

  • Ironwood Pharmaceuticals' Debt to Equity fell 72.22% to -$2.21 in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.34, marking a year-over-year decrease of 27.00%. This contributed to the annual value of -$1.28 for FY2024, which is 11.43% up from last year.
  • Latest data reveals that Ironwood Pharmaceuticals reported Debt to Equity of -$1.28 as of FY2024, which was up 11.43% from -$1.44 recorded in FY2023.
  • Ironwood Pharmaceuticals' Debt to Equity's 5-year high stood at $0.19 during FY2021, with a 5-year trough of -$1.44 in FY2023.
  • Over the past 2 years, Ironwood Pharmaceuticals' median Debt to Equity value was -$1.36 (recorded in 2023), while the average stood at -$1.36.
  • Data for Ironwood Pharmaceuticals' Debt to Equity shows a peak YoY rose of 11.43% (in 2024) over the last 5 years.
  • Yearly analysis of 3 years shows Ironwood Pharmaceuticals' Debt to Equity stood at $0.19 in 2021, then reached -$1.44 in 2023, then rose by 11.43% to -$1.28 in 2024.